Table 3.
Number and rate of the ST-1 and ST-17 strains detected by the analysis of the matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) spectra, and the number and rate of the erythromycin and clindamycin resistant strains among them.
| Sequence Type | No. of Strains Detected (%) | Erythromycin Resistant Strains (%) | Clindamycin Resistant Strains (%) |
Strains Resistant to Clindamycin Alone (%) | Erythromycin-Clindamycin Co-Resistant Strains (%) |
|---|---|---|---|---|---|
| ST-1 | 71 (27.3) | 37 (52.1) | 37 (52.1) | 0 (0) | 37 (52.1) |
| ST-17 | 50 (19.2) | 16 (32.0) | 17 (34.0) | 1 (2.0) | 16 (32.0) |
| Other (non-ST-1, non-ST-17) |
139 (53.5) | 43 (30.9) | 47 (33.8) | 4 (2.9) | 43 (30.9) |